CvergenX, Inc. - Testimony

Document ID: FDA-2010-N-0274-0005
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: July 15 2010, at 12:00 AM Eastern Daylight Time
Date Posted: July 20 2010, at 12:00 AM Eastern Standard Time
Comment Start Date: June 17 2010, at 12:00 AM Eastern Standard Time
Comment Due Date: August 15 2010, at 11:59 PM Eastern Standard Time
Tracking Number: 80b1a70f
View Document:

This is comment on Notice

Meetings: Oversight of Laboratory Developed Tests

View Comment

Presentation at FDA public meeting on Oversight of Laboratory Developed Tests on July 19th and 20th at the Marriott Inn and Conference Center in Hyattsville, MD. Presenter number 38 in Session 2: Oversight of LDTs: Clinical Laboratory Challenges Attached are comments. Thank you.

Attachments:

CvergenX, Inc. - Testimony

Title:
CvergenX, Inc. - Testimony

View Attachment:

Related Comments

View All

Total: 96

Marie Louise Landry, Yale University and Yale New Haven Hospital - Testimony
Public Submission Posted: 07/13/2010 ID: FDA-2010-N-0274-0003